T1	Participants 67 117	patients with advanced non-small-cell lung cancer.
T2	Participants 311 346	patients with advanced lung cancer.
T3	Participants 490 554	Twelve patients with advanced non-small-cell lung cancer (NSCLC)
T4	Participants 805 823	¿3-(13)Călanine.
T5	Participants 824 875	Thirteen NSCLC patients and eleven healthy subjects
